Thomas Vanwolleghem

Deputy Head

Antwerp University Hospital

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Thomas Vanwolleghem is the Deputy Head at Antwerp University Hospital in Belgium. His research primarily focuses on various aspects of liver diseases, including chronic hepatitis B, hepatocellular carcinoma, and hepatitis E. His recent publications address topics such as the risk of severe liver-related outcomes, portal hypertension, and innovative detection methods for hepatitis B virus mRNA. Dr. Vanwolleghem's work aims to enhance patient care through improved understanding of liver conditions and treatment responses.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (3)

Pietro Lampertico

University of Milan

ITALY

View details

Ann Driessen

Adjunct-head, pathologist

Universitair Ziekenhuis Antwerpen

BELGIUM

View details

Florian van Bömmel

Professor of Medicine

University Hospital Leipzig

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Vanwolleghem

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

An unusual case of acute cholestatic hepatitis: visceral leishmaniasis with secondary haemophagocytic lymphohistiocytosis

Unexplained portal hypertension and confusion in an elderly patient: a late presentation of congenital hepatic fibrosis

Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in chronic hepatitis B patients with advanced fibrosis

Acute hepatitis E-related Guillain-Barré syndrome

Detection of hepatitis B virus mRNA from single cell RNA sequencing data without prior knowledge

Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B

Severe liver‐related outcomes in patients with hepatitis delta

The clinical relevance of prior metabolic and bariatric surgery in alcohol-related liver disease in a nationwide Belgian liver transplant population

Unraveling Hepatitis E Virus susceptibility to heat treatment, pH reduction and drying in pork meat

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2

Collaborators (3)

Pietro Lampertico

Ann Driessen

Florian van Bömmel

Make your next move.